Treatment with mitoTEMPO also recovered other indicators of mitochondrial function such as PGC-1α and ATP5a-1 levels and the mitochondrial length/width ratio in ischemic reperfusion induced AKI [145]. This evidence concerns the gene PPARGC1A and acute kidney injury.